Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
New ‘Cloud-9’ object could reveal the secrets of dark matter08.01.2026 - 2Journeys That could only be described as epic: Delightful Voyage Lines All over the Planet06.06.2024
- 3Step by step instructions to Pick the Right Web-based Degree Program17.10.2023
- 4Rachael Ray is navigating grief this holiday season. She doesn't have time for 'negative energy' on the internet.22.12.2025
- 5Israel faces widespread condemnation as NGO ban comes into effect01.01.2026
- These 3 Nail-Free Finds Completely Transformed My Drab Bathroom
- Holiday weather forecast: Where travelers can expect a wintry mix, flooding and record warmth across the U.S.
- 6 Agreeable Earphones To Wear
- Overlooked infertility care should be part of national health services, says WHO
- Dominating Online Entertainment Showcasing: 7 Hints for Organizations
- The Extraordinary Excursion of Dental Embed Innovation
- Nations for Youngsters to Visit
- Slims down for Maintainable Weight reduction
- Instructions to Improve Your Mental Exploration with Cutting edge Measurements
